Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Buy
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
China Pharma Holdings, Inc. (CPHI)
Pharmaceutical Preparations
https://www.chinapharmaholdings.com
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection, and others.
2ND FLOOR, NO. 17, JINPAN ROAD, HAIKOU
HAINAN PROVINCE, F4
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
04/14/2002
Market Cap
2,951,839
Shares Outstanding
53,070,000
Weighted SO
53,066,682
Total Employees
N/A
Upcoming Earnings
N/A
Beta
0.7260
Last Div
0.0000
Range
0.17-1.75
Chg
0.0020
Avg Vol
351725
Mkt Cap
2951839
Exch
AMEX
Country
CN
Phone
86 89 8668 11730
DCF Diff
-1.1700
DCF
-0.9400
Div Yield
0.0000
P/S
0.0000
EV Multiple
-0.5336
P/FV
0.4048
Div Yield %
0.0000
P/E
-2.0854
PEG
-0.0393
Payout
0.0000
Current Ratio
0.8432
Quick Ratio
0.2449
Cash Ratio
0.1569
DSO
100.5681
DIO
530.2732
Op Cycle
630.8412
DPO
26.5305
CCC
604.3107
Gross Margin
-1.0978
Op Margin
-1.5044
Pretax Margin
-1.5548
Net Margin
-1.5548
Eff Tax Rate
0.0000
ROA
-0.1008
ROE
-0.7765
ROCE
-0.1457
NI/EBT
1.0000
EBT/EBIT
1.0335
EBIT/Rev
-1.5044
Debt Ratio
0.1039
D/E
0.2000
LT Debt/Cap
0.1592
Total Debt/Cap
0.1667
Int Coverage
28.9057
CF/Debt
0.0000
Equity Multi
1.9250
Rec Turnover
3.6294
Pay Turnover
13.7577
Inv Turnover
0.6883
FA Turnover
0.1569
Asset Turnover
0.0649
OCF/Share
0.0000
FCF/Share
0.0000
Cash/Share
0.0459
OCF/Sales
0.0000
FCF/OCF
0.9887
CF Coverage
0.0000
ST Coverage
0.0000
CapEx Coverage
88.3157
Div&CapEx Cov
88.3157
P/BV
0.4048
P/B
0.4048
P/S
0.0000
P/E
-2.0854
P/FCF
7.4678
P/OCF
999999.9999
P/CF
999999.9999
PEG
-0.0393
P/S
0.0000
EV Multiple
-0.5336
P/FV
0.4048
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
13.76M Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 3.24M | ▼ 3.05M | ▼ 2.93M | ▼ 2.89M | ▲ 2.92M | ▼ 2.15M | ▼ 1.37M |
Cost Of Revenue | 3.41M | ▼ 2.76M | ▼ 2.37M | ▲ 2.59M | ▲ 2.88M | ▼ 2.29M | ▼ 1.66M |
Gross Profit | -170.88K | ▲ 289.35K | ▲ 561.47K | ▼ 301.94K | ▼ 42.68K | ▼ -141.42K | ▼ -290.02K |
Gross Profit Ratio | -0.05 | ▲ 0.09 | ▲ 0.19 | ▼ 0.10 | ▼ 0.01 | ▼ -0.07 | ▼ -0.21 |
Research And Development Expenses | 64.44K | ▼ 54.00K | ▲ 261.47K | ▼ 54.05K | ▼ 28.00K | ▲ 147.55K | ▼ 31.45K |
General And Administrative Expenses | 777.61K | ▲ 1.19M | ▼ 821.07K | ▼ 610.30K | ▲ 829.43K | ▼ 689.79K | ▼ 488.46K |
Selling And Marketing Expenses | 896.31K | ▼ 754.94K | ▼ 507.57K | ▲ 536.90K | ▼ 364.40K | ▼ 259.55K | ▼ 108.19K |
Selling General And Administrative Expenses | 796.52K | ▲ 1.90M | ▼ 1.40M | ▼ 896.58K | ▲ 1.18M | ▼ 895.52K | ▼ 596.64K |
Other Expenses | 7.08T | ▲ 17.02T | ▼ 115.19B | ▼ 0.00 | ▲ 10.14K | ▼ -4.05B | ▲ 0.00 |
Operating Expenses | -7.34M | ▼ -18.96M | ▲ -1.66M | ▲ -950.63K | ▲ 1.22M | ▼ 1.04M | ▼ 628.09K |
Cost And Expenses | -3.93M | ▼ -16.21M | ▲ 706.66K | ▲ 1.64M | ▲ 1.67M | ▲ 3.33M | ▼ 2.29M |
Interest Income | 10.59K | ▼ 311.00 | ▲ 412.00 | ▲ 1.41K | ▼ 1.00K | ▲ 2.53K | ▼ 2.32K |
Interest Expense | -79.31K | ▲ -69.78K | ▼ -107.53K | ▼ -332.03K | ▲ -95.17K | ▲ 50.25K | ▼ -42.16K |
Depreciation And Amortization | -759.63K | ▲ -667.00K | ▼ -701.11K | ▼ -710.72K | ▲ 649.56K | ▲ 695.84K | ▲ 733.80K |
Ebitda | -272.21K | ▼ -993.36K | ▲ -400.40K | ▲ 62.03K | ▼ -529.59K | ▲ -488.65K | ▼ -916.05K |
Ebitda Ratio | -0.08 | ▼ -0.33 | ▲ -0.14 | ▲ 0.02 | ▼ -0.18 | ▼ -0.23 | ▼ -0.67 |
Operating Income | -1.03M | ▼ -1.66M | ▲ -1.10M | ▲ 772.74K | ▼ -1.18M | ▼ -1.18M | ▲ -916.05K |
Operating Income Ratio | -0.32 | ▼ -0.54 | ▲ -0.38 | ▲ 0.27 | ▼ -0.40 | ▼ -0.55 | ▼ -0.67 |
Total Other Income Expenses Net | -6.56M | ▼ -17.08M | ▲ -107.53K | ▼ -1.75M | ▲ -85.04K | ▲ -47.72K | ▲ -39.84K |
Income Before Tax | -7.59M | ▼ -18.75M | ▲ -1.21M | ▲ -980.72K | ▼ -1.26M | ▲ -1.23M | ▲ -955.89K |
Income Before Tax Ratio | -2.34 | ▼ -6.15 | ▲ -0.41 | ▲ -0.34 | ▼ -0.43 | ▼ -0.57 | ▼ -0.70 |
Income Tax Expense | 1.92K | ▼ -54.71K | ▲ -42.31K | ▲ 2.09M | ▼ 83.72K | ▼ 3.00 | ▼ -733.80K |
Net Income | -7.59M | ▼ -18.75M | ▲ -1.21M | ▼ -3.07M | ▲ -1.35M | ▲ -1.23M | ▲ -955.89K |
Net Income Ratio | -2.34 | ▼ -6.15 | ▲ -0.41 | ▼ -1.06 | ▲ -0.46 | ▼ -0.57 | ▼ -0.70 |
Eps | -1.74 | ▼ -4.30 | ▲ -0.28 | ▲ -0.21 | -0.21 | ▲ -0.12 | ▲ -0.07 |
Eps Diluted | -1.74 | ▼ -4.30 | ▲ -0.28 | ▲ -0.21 | -0.21 | ▲ -0.12 | ▲ -0.07 |
Weighted Average Shs Out | 4.36M | ▼ 4.36M | ▲ 4.38M | ▲ 4.78M | ▲ 6.44M | ▲ 10.63M | ▲ 13.13M |
Weighted Average Shs Out Dil | 4.36M | 4.36M | ▲ 4.38M | ▲ 4.78M | ▲ 6.44M | ▲ 10.63M | ▲ 13.13M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 1.19M | ▼ 1.07M | ▼ 957.65K | ▲ 4.86M | ▼ 2.03M | ▼ 1.42M | ▼ 838.88K |
Short Term Investments | 0.00 | 0.00 | 0.00 | ▲ 91.36K | ▼ 13.78K | ▲ 65.92K | ▼ 0.00 |
Cash And Short Term Investments | 1.19M | ▼ 1.07M | ▼ 957.65K | ▲ 4.86M | ▼ 2.03M | ▼ 1.49M | ▼ 838.88K |
Net Receivables | 1.11M | ▼ 727.77K | ▼ 583.28K | ▲ 835.40K | ▼ 464.45K | ▲ 662.39K | ▼ 358.77K |
Inventory | 5.05M | ▼ 3.59M | ▲ 3.71M | ▼ 3.34M | ▼ 2.95M | ▲ 3.73M | ▼ 3.68M |
Other Current Assets | 1.40M | ▼ 187.43K | ▼ 75.91K | ▼ 59.26K | ▲ 565.26K | ▼ 110.26K | ▲ 247.56K |
Total Current Assets | 8.75M | ▼ 5.58M | ▼ 5.32M | ▲ 9.09M | ▼ 5.96M | ▲ 6.00M | ▼ 5.12M |
Property Plant Equipment Net | 18.88M | ▼ 16.05M | ▼ 15.18M | ▼ 12.97M | ▼ 9.61M | ▼ 7.22M | ▼ 6.55M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 676.06K | ▼ 609.37K | ▲ 613.83K | ▼ 589.62K | ▲ 2.21M | ▲ 3.65M | ▲ 4.52M |
Goodwill And Intangible Assets | 676.06K | ▼ 609.37K | ▲ 613.83K | ▼ 589.62K | ▲ 2.21M | ▲ 3.65M | ▲ 4.52M |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 17.07M | ▼ -16.66M | ▲ -15.80M | ▲ -13.56M | ▲ -11.82M | ▲ -397.68K | ▲ 0.00 |
Total Non Current Assets | 36.63M | ▼ 16.66M | ▼ 15.80M | ▼ 13.56M | ▼ 11.82M | ▼ 10.47M | ▲ 11.07M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Assets | 45.38M | ▼ 22.24M | ▼ 21.12M | ▲ 22.65M | ▼ 17.78M | ▼ 16.47M | ▼ 16.19M |
Account Payables | 1.06M | ▲ 1.37M | ▼ 1.23M | ▼ 926.75K | ▼ 667.08K | ▲ 966.42K | ▼ 647.83K |
Short Term Debt | 3.46M | ▼ 2.35M | ▲ 6.52M | ▲ 7.19M | ▲ 8.76M | ▼ 3.18M | ▼ 78.28K |
Tax Payables | 0.00 | 0.00 | 0.00 | ▲ 841.62K | ▲ 1.07M | ▼ 1.03M | ▼ 853.72K |
Deferred Revenue | 525.65K | ▼ 505.40K | ▲ 719.79K | ▼ 210.03K | ▲ 520.30K | ▼ 90.51K | ▲ 112.36K |
Other Current Liabilities | 5.01M | ▲ 5.82M | ▼ 2.93M | ▼ 2.18M | ▲ 2.79M | ▼ 2.58M | ▲ 4.89M |
Total Current Liabilities | 10.05M | ▼ 10.05M | ▲ 11.40M | ▼ 10.51M | ▲ 12.74M | ▼ 6.82M | ▼ 5.73M |
Long Term Debt | 4.36M | ▼ 2.20M | ▼ 904.23K | ▲ 5.29M | ▼ 0.00 | ▲ 1.41M | ▼ 1.41M |
Deferred Revenue Non Current | -4.36M | ▲ -2.15M | ▲ 904.23K | ▼ -5.25M | ▲ 0.00 | 0.00 | 0.00 |
Deferred Tax Liabilities Non Current | 764.37K | ▼ 753.44K | ▲ 805.56K | ▲ 824.41K | ▼ 754.70K | ▼ 742.11K | ▼ 740.83K |
Other Non Current Liabilities | 4.36M | ▼ 2.15M | ▼ 0.00 | ▲ 5.25M | ▼ 0.00 | ▲ 39.91K | ▼ 20.01K |
Total Non Current Liabilities | 5.13M | ▼ 2.95M | ▼ 1.71M | ▲ 6.12M | ▼ 754.70K | ▲ 2.19M | ▼ 2.17M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Capital Lease Obligations | 0.00 | ▲ 140.01K | ▼ 52.07K | ▲ 129.46K | ▼ 40.45K | ▼ 39.91K | ▲ 78.28K |
Total Liabilities | 15.18M | ▼ 13.00M | ▲ 13.11M | ▲ 16.63M | ▼ 13.49M | ▼ 9.01M | ▼ 7.90M |
Preferred Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock | 43.58K | 43.58K | ▲ 45.58K | ▲ 47.34K | ▲ 74.91K | ▼ 10.63K | ▲ 14.82K |
Retained Earnings | -5.27M | ▼ -25.97M | ▼ -28.84M | ▼ -32.24M | ▼ -36.21M | ▼ -39.29M | ▼ -40.25M |
Accumulated Other Comprehensive Income Loss | 11.84M | ▼ 11.58M | ▲ 12.35M | ▲ 12.56M | ▼ 11.57M | ▼ 11.45M | ▼ 11.43M |
Other Total Stockholders Equity | 23.59M | 23.59M | ▲ 24.45M | ▲ 25.65M | ▲ 28.85M | ▲ 35.28M | ▲ 37.09M |
Total Stockholders Equity | 30.20M | ▼ 9.24M | ▼ 8.00M | ▼ 6.02M | ▼ 4.29M | ▲ 7.45M | ▲ 8.29M |
Total Equity | 30.20M | ▼ 9.24M | ▼ 8.00M | ▼ 6.02M | ▼ 4.29M | ▲ 7.45M | ▲ 8.29M |
Total Liabilities And Stockholders Equity | 45.38M | ▼ 22.24M | ▼ 21.12M | ▲ 22.65M | ▼ 17.78M | ▼ 16.47M | ▼ 16.19M |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 45.38M | ▼ 22.24M | ▼ 21.12M | ▲ 22.65M | ▼ 17.78M | ▼ 16.47M | ▼ 16.19M |
Total Investments | 0.00 | 0.00 | 0.00 | ▲ 91.36K | ▼ 13.78K | ▲ 65.92K | ▼ 0.00 |
Total Debt | 7.82M | ▼ 4.55M | ▲ 7.43M | ▲ 12.49M | ▼ 8.76M | ▼ 4.63M | ▼ 1.49M |
Net Debt | 6.63M | ▼ 3.48M | ▲ 6.47M | ▲ 7.63M | ▼ 6.73M | ▼ 3.21M | ▼ 648.85K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -7.59M | ▼ -18.75M | ▲ -1.21M | ▲ -980.72K | ▼ -1.26M | ▲ -1.23M | ▲ -955.89K |
Depreciation And Amortization | 759.63K | ▼ 667.00K | ▲ 701.11K | ▲ 710.72K | ▼ 639.43K | ▲ 695.84K | ▲ 733.80K |
Deferred Income Tax | -1.20K | ▲ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Stock Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 78.27K | ▼ 0.00 | 0.00 |
Change In Working Capital | 527.02K | ▼ 153.41K | ▲ 769.93K | ▼ 220.90K | ▲ 1.14M | ▼ 505.82K | ▼ -361.00K |
Accounts Receivables | 99.40K | ▼ -478.92K | ▼ -613.68K | ▼ -687.72K | ▲ -170.19K | ▼ -364.26K | ▲ 120.37K |
Inventory | 216.86K | ▲ 563.10K | ▼ 246.45K | ▲ 255.82K | ▼ 192.90K | ▲ 250.69K | ▲ 264.35K |
Accounts Payables | 499.82K | ▼ 193.54K | ▼ 185.35K | ▲ 311.02K | ▼ 238.49K | ▼ 107.92K | ▼ -316.57K |
Other Working Capital | -99.40K | ▲ 478.92K | ▲ 613.68K | ▲ 687.72K | ▲ 880.03K | ▼ 511.47K | ▼ -429.15K |
Other Non Cash Items | 6.56M | ▲ 17.13M | ▼ 72.87K | ▼ -149.01K | ▲ -10.14K | ▲ 8.24K | ▲ 1.40M |
Net Cash Provided By Operating Activities | 249.30K | ▼ -795.37K | ▲ 334.87K | ▼ -198.11K | ▲ 584.59K | ▼ -22.32K | ▼ -585.16K |
Investments In Property Plant And Equipment | -17.81K | ▼ -50.26K | ▲ 232.57K | ▼ -7.06K | ▼ -149.41K | ▲ -4.53K | ▲ 0.00 |
Acquisitions Net | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Sales Maturities Of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 176.68K | ▼ 55.96K | ▼ 0.00 |
Net Cash Used For Investing Activities | -17.81K | ▼ -50.26K | ▲ 232.57K | ▼ -7.06K | ▲ 27.27K | ▼ -4.53K | ▲ 0.00 |
Debt Repayment | -39.53K | ▲ -22.04K | ▼ -215.88K | ▼ -402.99K | ▼ -1.24M | ▲ -30.38K | ▲ -6.86K |
Common Stock Issued | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.71M | ▼ 1.65M | ▼ 1.37M |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 366.49K | ▼ 17.05K | ▲ 205.80K | ▲ 5.02M | ▼ -1.14M | ▼ -1.58M | ▲ -1.36M |
Net Cash Used Provided By Financing Activities | 326.96K | ▼ -4.99K | ▼ -10.08K | ▲ 4.62M | ▼ -672.06K | ▲ 30.38K | ▼ 6.86K |
Effect Of Forex Changes On Cash | -39.49K | ▲ -43.00 | ▲ 53.68K | ▼ -14.58K | ▲ 3.88K | ▲ 50.44K | ▼ -6.66K |
Net Change In Cash | 518.96K | ▼ 423.28K | ▲ 611.04K | ▲ 4.40M | ▼ -56.33K | ▲ 53.97K | ▼ -584.96K |
Cash At End Of Period | 1.19M | ▼ 1.18M | ▼ 957.65K | ▲ 4.86M | ▼ 2.03M | ▼ 1.42M | ▼ 838.88K |
Cash At Beginning Of Period | 667.63K | ▲ 761.61K | ▼ 346.61K | ▲ 458.83K | ▲ 2.09M | ▼ 1.37M | ▲ 1.42M |
Operating Cash Flow | 249.30K | ▼ -795.37K | ▲ 334.87K | ▼ -198.11K | ▲ 584.59K | ▼ -22.32K | ▼ -585.16K |
Capital Expenditure | -17.81K | ▼ -50.26K | ▲ 232.57K | ▼ -7.06K | ▼ -149.41K | ▲ -4.53K | ▲ 0.00 |
Free Cash Flow | 231.49K | ▼ -845.63K | ▲ 567.44K | ▼ -205.17K | ▲ 435.18K | ▼ -26.85K | ▼ -585.16K |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)